Fig 6.1 Drug released by diffusion

Slides:



Advertisements
Similar presentations
Atherosclerosis Mike Clark, M.D.. Terms Arteriosclerosis – hardening of the arteries Atherosclerosis – a form of arteriosclerosis Venosclerosis Arteriolosclerosis.
Advertisements

Pathologic Intimal Hyperplasia as a Response to Vascular Injury and Reconstruction.
Pathogenesis of Atherosclerosis Judith Berliner, Ph.D. Departments of Pathology and Medicine Division of Cardiology David Geffen School of Medicine at.
Stents Are Not Enough: Statins Keith Channon Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford.
PBL CV 2 Pathophysiology of coronary artery disease.
Θεματική ενότητα: Stenting Μ. Ματσάγκας, MD, PhD, FEBVS Σάββατο 9 Φεβρουαρίου 2013.
ATHEROSCLEROSIS Sufia Husain. Pathology. KSU. Riyadh. March 2015
RAMS Faculty/Mentor Workshop Kara Kruse Richard Ward Jim Nutaro Barbara Beckerman Computational Sciences and Engineering Division Oak Ridge, Tennessee.
Aging of the Cardiovascular System (continued)
ATHEROSCLEROSIS By Joshua Bower Easter Revision 2014
ATHEROSCLEROSIS Dr. Gehan Mohamed Dr. Abdelaty Shawky.
ATHEROSCLEROSIS Dr. Gehan mohamed
ATHEROSCLEROSIS. Atherosclerosis Atherosclerosis is a disease of large and medium-sized muscular arteries and is characterized by endothelial dysfunction,
Vascular wall biology with current generation stents Professor Martin Bennett BHF Professor of Cardiovascular Sciences, Cambridge.
Lipoprotein Structures, Function and Metabolism (4)
Atherosclerosis Hisham Al Khalidi. Vessel wall structure.
Atherosclerosis.
The Science Behind Taxus Advanced Angioplasty 2004 Christian Vander Velde, Boston Scientific Europe, Marketing.
03/06/231 K June /06/232 Atherosclerosis Etiology Classic Risk Factors Dyslipidemia Low HDL Epidemiological Studies (e.g. Framingham) Genetic.
Excessive SMC growth within the vascular wall after trauma -proliferation -apoptosis -migration - accelerated matrix deposition major cause of failure.
ATHEROSCLEROSIS Dr: Wael H.Mansy, MD Assistant Professor
The Atherosclerotic Process The progressive __________ and hardening of the artery due to the build up of _________.
Associate professor of pathology
Atherosclerosis CVS lecture 2 Atherosclerosis Shaesta Naseem.
Disorder of lipoprotein metabolism. Atherosclerosis Ph.D., MD, Assistant Professor Bakalets O.V.
Atherosclerosis CVS 1 Hisham Al Khalidi. Atherosclerosis.wmv.
FLOW THROUGH TUBES By Joshua Bower Peer Support 2013/2014
 Prof. A. M. Vollmar  PD Dr. V. M. Dirsch  Thomas Roos  Nancy Lopez WP 5: Cardiovascular diseases 5.1: The Interaction of garlic with mediators of.
atherosclerosis Jon Yap John A. Burns School of Medicine
Atherosclerosis CVS lecture 2 Atherosclerosis. Vessel wall structure.
ATHEROSCLEROSIS Dr. Gehan Mohamed Dr. Abdelaty Shawky.
Repair 2 Dr Heyam Awad FRCpath.
Dr.Hesham Rashid, MD PATHOGENIC MECHANISMS OF ATHEROSCLEROSIS
ATHEROSCLEROSIS DR.SAMINA QAMAR ASSISTANT PROFESSOR HISTOPATHOLOGY.
Cardiovascular disease 1/Pathology of cardiovascular disease (CVD) - Effect of artherosclerosis and its links to cardiovascular disease (CVD) - Thrombosis.
Boston Scientific Drug eluting stent program A Scientific Approach Identify therapeutic agent Identify appropriate polymer carrier Evaluate a broad range.
DES arena THE CURRENT APPROACH TO DES MARKET IS BASED ON DRUG
Atherosclerosis. Atherosclerosis Most common form of vascular disease Caused by a build up plaque in the tunica intima Narrows the lumen.
LOGO Presenter : S.Mohammad Zargar Supervisor : Dr. Mahdikhani Faculty of Engineering Department of Biomedical Engineering.
DRug Eluting Bbsorbable Metal Scaffold (DREAMS)
Is atherosclerosis a metabolic disease?
“The Percutaneous Revolution” The Surgeon’s Perspective William O
B – The Cardiovascular System
Peter Libby, MD  The American Journal of Medicine 
Design of a Biodegradable Vascular Construct
CLS 223.
Stent thrombosis of drug eluting stent: Pathological perspective
One DES Eluting Two Drugs: Is it Feasible?
Arterial circulation.
Atherosclerosis.
Section II: A primer on the endothelium
Section I: RAS manipulation
Gaku Nakazawa et al. JIMG 2009;2:
Blood clotting.
Chapter 12 Pathophysiology of Atherosclerosis
Nat. Rev. Cardiol. doi: /nrcardio
Arterial wall: structure and function
Section 4: Plaque dynamics and stenosis
Figure 1 Mechanisms of platelet adhesion and aggregation
Volume 5, Issue 3, Pages (December 1998)
Endothelial function: Changing the pattern of treating CV disease
Atherosclerosis Dr:HAMED ALGHAMDI.
Early Fistula Failure: Back to Basics
The Biological Role of Inflammation in Atherosclerosis
Macrophages in the Pathogenesis of Atherosclerosis
MicroRNA-21 and the Vulnerability of Atherosclerotic Plaques
Impaired Lung Function and Risk for Stroke
Atherosclerosis  Christopher K. Glass, Joseph L. Witztum  Cell 
Prevention of stenosis after vascular reconstruction: Pharmacologic control of intimal hyperplasia—A review  Alexander W. Clowes, MD, Michael A. Reidy,
Presentation transcript:

Fig 6.1 Drug released by diffusion Drug diffusion through additional polymer coating Drug release by swelling of coating Drug release by coating erosion Polymer drug conjugate cleaved by hydrolysis or enzymic action Biodegradable polymeric stent Drug loaded in stent reservoir Stent Polymer Drug Fig 6.1

Thrombus organization Thrombus formation Anti-inflammatory drugs SMC activation Endothelial denudation Vascular injury Angioplasty Proliferation DNA synthesis Restenosis Extracellular matrix formation ECM modulators Antiproliferative agents Thrombus organization Thrombus formation Anti-inflammatory drugs Negative arterial remodeling Migration Antimigratory Recoil Mechanical stretch Stent Antiplatelet therapy Fig 6.2

Fig 6.3 Smooth muscle cells Tissue factor Cholesterol Necrotic core Foam cells Rupture of plaque Platelets Vascular endothelium Atherosclerotic plaque Vessel wall Thrombus Fig 6.3